Skip to main content

Parkwalk Advisors — Portfolio, Page 2

Investor actively backing innovative startups and growth-stage companies across various industries and funding rounds.

173
Companies
$2.3B
Total invested
$13.4M
Avg. check
50
Industries
Biotechnology 7Health Care 6Software 6Manufacturing 4Artificial Intelligence (AI) 4Medical 4+44 more
Founder contacts

Verified emails & LinkedIn for founders across this portfolio.

jane@on●●●●●●●.com
linkedin.com/in/●●●●●●
Verified contacts, updated monthly
Get instant access →

Portfolio companies

Showing 25–48 of 173
Cambridge Photon Technology
November 2025

Cambridge Photon Technology is a developer of organic photovoltaic devices used to enhance next-generation solar technology.

Energy · Cambridge$1.2M Venture - Series Unknown
NoBACZ
September 2025

NoBACZ is pioneering a novel, new precision bandaging platform for the veterinary and human market.

Health Care · Cambridge$6.4M Venture - Series Unknown
Trismik
September 2025

Trismik is an early-stage company specializing in efficient real-world evaluations, particularly for LLMs.

Information Technology · Cambridge$3.0M Pre-Seed
Duel
September 2025

A Brand Advocacy Platform that enables brands to transform customers into their biggest acquisition channel

Advertising · London$16.0M Series A
Enhanc3D Genomics
September 2025

Enhanc3D Genomics is a functional genomics company exploring the 3D organization of DNA in health and disease.

Biotechnology · Cambridge$5.4M Series A
Xampla
September 2025

Xampla develops natural, biodegradable materials as sustainable alternatives to traditional plastics.

Biotechnology · Cambridge$14.0M Series A
Phasecraft
September 2025

Phasecraft develops quantum algorithms and related intellectual property for scientific and industrial applications.

Computer · London$34.0M Series B
Paragraf
August 2025

Paragraf develops and manufactures graphene-based electronic devices for the sensors and diagnostics markets.

Advanced Materials · Somersham$55.0M Series C
Bitfount
July 2025

Federated data science and AI platform for privacy-preserving analytics & AI/ML

Analytics · London$8.0M Series A
Ceryx Medical
June 2025

Ceryx Medical is developing bioelectronics based on unique, patent protected, chip technology.

Health Care · Bath$6.8M Venture - Series Unknown
AccelerComm
May 2025

AccelerComm is a semiconductor IP-core company specialising in channel coding solutions.

Semiconductor · Southampton$15.0M Venture - Series Unknown
Zentraxa
May 2025

Zentraxa has specialise in the design, production and testing of complex novel peptides.

Biotechnology · BristolSeed
Healthera
April 2025

Transforming the way a nation delivers its healthcare to its population, from prescriptions to personalised services.

Health Care · Cambridge$2.6M Series A
Psyomics
April 2025

PsyOmics develops proteomic diagnostics to improve early diagnosis and treatment outcomes for those with neuropsychiatric disorders.

Biotechnology · CambridgeNon-equity Assistance
PervasID
April 2025

PervasID is developing a high reliability

Developer Tools · Cambridge$264K Venture - Series Unknown
Diffblue
March 2025

Diffblue is a developer of automated testing software that enhances Java development by automatically generating unit tests.

Artificial Intelligence (AI) · Oxford$1.3M Grant
OSSTEC
March 2025

The next step forward in orthopaedics

3D Printing · London$3.2M Seed
Brainomix
March 2025

Brainomix specializes in the creation of AI-powered imaging biomarkers that enable precision medicine for better treatment decisions

Artificial Intelligence (AI) · Oxford$18.2M Series C
Cambridge GaN Devices
February 2025

Cambridge GaN Devices is a semiconductor company focused on developing GaN power devices aimed at creating greener electronics.

Electronics · Cambridge$32.0M Series C
RoboK
January 2025

RoboK is a computer vision startup with a mission to make all industrial workplaces safe and high-performing with AI.

Artificial Intelligence (AI) · Cambridge$1.1M Grant
Oxford Flow
December 2024

Oxford Flow is able to save money without sacrificing performance.

Clean Energy · Oxford$25.0M Series C
Abselion
December 2024

Abselion is the biological sensor for rapid and cost-effective detection of biological substances.

Biotechnology · Cambridge$8.4M Series A
Natrox
December 2024

Natrox is a wound care company that offers innovative technologies for healthcare professionals for chronic wounds.

Health Care · Cambridge$33.0M Series C
pixlbio (formerly DefiniGEN)
November 2024

Generating pre-clinical human data for therapeutic candidates with in-vitro liver and metabolic disease models.

Biotechnology · Cambridge$136K Undisclosed

Where Parkwalk Advisors invests

Biotechnology7
Health Care6
Software6
Manufacturing4
Artificial Intelligence (AI)4
Medical4

About Parkwalk Advisors's portfolio

How many companies has Parkwalk Advisors invested in?▸

Parkwalk Advisors has invested in 173 companies tracked in our database. The portfolio spans multiple industries and funding stages, from seed-stage startups to late-stage companies.

What industries does Parkwalk Advisors invest in?▸

Parkwalk Advisors's top investment sectors include Biotechnology, Health Care, Software, Manufacturing, Artificial Intelligence (AI). The firm invests across 50 different industry categories.

What is Parkwalk Advisors's largest investment?▸

Among tracked funding rounds, Paragraf received $55.0M in a Series C round. Parkwalk Advisors's total known invested capital is $2.3B.

What is the average investment size for Parkwalk Advisors?▸

Parkwalk Advisors's average investment size is $13.4M across its portfolio of 173 companies.

What are Parkwalk Advisors's most recent investments?▸

Recent Parkwalk Advisors portfolio additions include Cambridge Photon Technology, NoBACZ, Trismik, Duel, Enhanc3D Genomics. These companies were founded in 2020 or later.

Reach the founders behind these 173 companies
Verified emails and LinkedIn profiles, updated monthly.
Get instant access →